公开(公告)号：US11839636B1

公开(公告)日：2023-12-12

申请号：US17815548

申请日：2022-07-27

Applicant: Babry Oren ,  Sasha Moshe

Inventor： Babry Oren ,  Sasha Moshe

IPC: A61K36/15 ,  A61K36/87 ,  A61K36/906 ,  A61K9/00 ,  A61K36/31 ,  A61K36/67 ,  A61K36/82

CPC classification number: A61K36/15 ,  A61K9/0056 ,  A61K36/31 ,  A61K36/67 ,  A61K36/82 ,  A61K36/87 ,  A61K36/906

Abstract: A pharmaceutical composition containing dry powder of pine (Pinus) needles and dry peels and pits of grapes extract and pharmaceutically acceptable additive, dry extracts of ginger (Zingiber officinale), green tea (Camellia sinensis), yellow ginger (Curcuma longa), yellow mustard (Brassica hirta) seeds, white pepper, pomegranate (Punica granatum) bark and dry powder of pomegranate (Punica granatum) juice.

公开(公告)号：US20230146331A1

公开(公告)日：2023-05-11

申请号：US18149101

申请日：2022-12-31

Applicant: Babry Oren ,  Sasha Moshe

Inventor： Babry Oren ,  Sasha Moshe

IPC: A61K36/15 ,  A61K36/87 ,  A61K36/906 ,  A61K36/9066 ,  A61K36/65 ,  A61K36/41 ,  A61K36/736 ,  A61K36/07 ,  A61K36/28 ,  A61K36/16 ,  A61K36/67 ,  A61K36/61 ,  A61K36/73 ,  A61K31/525

CPC classification number: A61K36/15 ,  A61K31/525 ,  A61K36/07 ,  A61K36/16 ,  A61K36/28 ,  A61K36/41 ,  A61K36/61 ,  A61K36/65 ,  A61K36/67 ,  A61K36/73 ,  A61K36/87 ,  A61K36/736 ,  A61K36/906 ,  A61K36/9066

Abstract: A pharmaceutical composition containing dry powder of pine (Pinus) needles and dry peels and pits of grapes extract and pharmaceutically acceptable additive, dry extracts of ginger (Zingiber officinale), turmeric (Curcuma longa), white peony (Paeonia), Rhodiola Rosea (Rhodiola Rosea), apricot (Prunus) seed, oyster mushroom (Pleurotus ostreatus), green tea (Camellia sinensis), Ginkgo Biloba (Ginkgo biloba), white pepper, pomegranate (Punica granatum) pulp, medlar (Mespilus germanica), dry powder of pomegranate (Punica granatum) juice and folic acid, in the following ratio of the components in weight % (w %):








dry powder of pine needles and dry peels and pits of grapes extract and pharmaceutically acceptable additive
6-24


dry extract of ginger
6-25


dry extract of turmeric
5-24


dry extract of white peony
2-20


dry extract of Rhodiola Rosea
2-20


dry extract of apricot seed
5-20


dry extract of oyster mushroom
10-34


dry extract of green tea
12-35


dry extract of Ginkgo Biloba
2-25


dry extract of white pepper
1-15


dry extract of pomegranate pulp
2-20


extract of medlar
2-20


dry powder of pomegranate juice
2-25


folic acid
3-30

公开(公告)号：US20230051702A1

公开(公告)日：2023-02-16

申请号：US17977969

申请日：2022-10-31

Applicant: Monir Elias

Inventor： Monir Elias

IPC: A61K31/366 ,  A61K31/198 ,  A61K31/351 ,  A61K36/906 ,  A23L2/395 ,  A61K36/67

Abstract: A composition for mitigating, treating, and/or preventing symptoms associated with veisalgia. In one embodiment the composition comprises one or more ingredients selected from the group consisting of: dihydromyricetin, N-acetyl cysteine, salicin, quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, monk fruit, turmeric, curcumin, ginger root, and black pepper extract. A method for treating symptoms associated with veisalgia is also described. In one embodiment, the composition is administered in liquid or pill form.

公开(公告)号：US20230021051A1

公开(公告)日：2023-01-19

申请号：US17780590

申请日：2020-10-16

Applicant: Maruzen Pharmaceuticals Co., Ltd.

Inventor： Takashi Tagawa ,  Jun Ogasawara

IPC: A61K36/906 ,  A61K47/61

Abstract: A composition containing black ginger extract including black ginger extract, and cyclodextrin. The composition containing black ginger extract includes certain 6 polymethoxyflavones (6PMF). When a total amount of 6PMF in the composition containing black ginger extract is determined as 100 parts by mass, an amount of 5-hydroxy-7-methoxyflavone in the composition containing black ginger extract is 5 parts by mass or less. When absorbance of an aqueous solution of the composition containing black ginger extract, in which a total amount of the 6 polymethoxyflavones is adjusted to a certain amount, is measured, the absorbance of the aqueous solution satisfies P1/V1≥1.45.

公开(公告)号：US11382945B2

公开(公告)日：2022-07-12

申请号：US16448298

申请日：2019-06-21

Applicant: SRM INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Karunanidhi Santhana Lakshmi ,  Marakanam Srinivasan Uma Shankar ,  Vellapandian Chitra ,  Mohan Sumithra ,  Thangavel Mahalingam Vijaya Kumar

IPC: A61K36/484 ,  A61K47/46 ,  A61K36/38 ,  A61K36/53 ,  A61K36/736 ,  A61K36/899 ,  A61K36/81 ,  A61K36/55 ,  A61K36/906 ,  A61K31/7004 ,  A61K9/00 ,  A61K9/28 ,  A61K9/20 ,  A61K9/48 ,  A61K36/23

Abstract: The present disclosure provides a polyherbal composition for preventing and alleviating Polycystic ovary syndrome. The composition comprises an insulin regulator selected from Cinnamomum zeylyanicum and Trigonella foenum, a blood sugar regulator selected from Garcinea cambogia and Emblica officinalis, a cholesterol lowering agent selected from Linum usittatissimum and Tribulus terrestris, a prolactin regulator selected from Vitex agnus-castus and Trachyspermum ammi, a cyst shrinking component selected from Zingiber officinale and Putranjiva roxburghii, an androgen regulator selected from Ocimum sanctum, Glycyrrhiza glabra and Mentha spicate, an adrenal gland regulator selected from Withania somnifera and Sesamum indicum, an inositol containing component selected from Oryza sativa and Cicer arietinum, a binder selected from Ferula foetida and Prunus amygdalus along with a pharmaceutically acceptable excipient.

公开(公告)号：US11123396B2

公开(公告)日：2021-09-21

申请号：US16312167

申请日：2017-08-19

Applicant: Aurea Biolabs Private Limited

Inventor： Sreeraj Gopi ,  Karthik Varma Ayiranazhi Covilakam ,  Joby Jacob

IPC: A61K36/906 ,  A61K36/31 ,  A61K36/736 ,  A61K36/185

Abstract: The present disclosure discloses a herbal formulation in powdered dosage form, which is useful to enhance the physical endurance or strength in athletes. The disclosure also includes a method of preparation of the formulation, which involves the encapsulation of the natural ingredients in a natural matrix. The formulation comprises Moringa oleifera, Kaempferia parviflora and Punica granatum that are processed to obtain the product in powder form by encapsulation of the natural ingredients in a natural matrix. The formulation increased the nitrate and nitrite levels in serum and saliva in human and is useful to improve the general health of the athletes.

公开(公告)号：US11026897B2

公开(公告)日：2021-06-08

申请号：US16536449

申请日：2019-08-09

Applicant: Metagenics, Inc.

Inventor： Nikhat Contractor ,  Jennifer Joan Ryan

IPC: A61K36/906 ,  A61K31/12 ,  A61K31/085 ,  A61K31/366 ,  A61P1/04 ,  A61K31/519 ,  A61K31/714 ,  A61K31/198 ,  A61K36/53

Abstract: A composition for treatment of inflammation in a mammal is provided. The mammal has a neutrophil to lymphocyte ratio (NLR). The composition includes a curcumagalactomannoside and a hops extract. The curcumagalactomannoside and the hops extract cooperate to decrease the NLR of the mammal 12 weeks after ingestion of the composition. A method of treatment of inflammation in a mammal is also provided. The method includes obtaining a parameter of the mammal. The method further includes dosing the composition based on the parameter. The method further includes administering the composition to the mammal.

公开(公告)号：US20210121516A1

公开(公告)日：2021-04-29

申请号：US16667450

申请日：2019-10-29

Applicant: Hope Christine Radellant

Inventor： Hope Christine Radellant

IPC: A61K36/906 ,  A61K36/73 ,  A61K36/752 ,  A61K35/644 ,  A61K36/8962

Abstract: The present invention is directed to an all natural treatment for asthma. The treatment is in liquid form and uses no toxic chemicals or preservatives. The composition includes ginger juice, apple cider vinegar, lemon, honey, CBD oil, and garlic.

公开(公告)号：US20200338016A1

公开(公告)日：2020-10-29

申请号：US16685529

申请日：2019-11-15

Applicant: Mark Edward Fenzl

Inventor： Mark Edward Fenzl

IPC: A61K31/05 ,  A61K31/353 ,  A61K31/11 ,  A61K31/085 ,  A61K31/4745 ,  A61K36/45 ,  A61K36/35 ,  A61K36/60 ,  A61K36/886 ,  A61K36/906 ,  A23L33/105 ,  A23L33/10 ,  A61K8/34 ,  A61K8/31 ,  A61K8/49 ,  A61K8/9789 ,  A61K8/9794

Abstract: Drug-resistant pathogens have led to disease and expense for health care, agriculture, and food industries. Synthetic chemicals have become less effective at killing antibiotic-resistant pathogens and there is not likely going to be the development of new antibiotics in the future. This disclosure provides for a combination broad-spectrum antibiotic using a combination of plant extracts that protect from drug-resistant pathogens.

公开(公告)号：US20200038341A1

公开(公告)日：2020-02-06

申请号：US16653647

申请日：2019-10-15

Applicant: Script Essentials, LLC

Inventor： Suzy Cohen

IPC: A61K31/10 ,  A23L33/17 ,  A23L33/105 ,  A61K33/04 ,  A61K38/39 ,  A61K36/324 ,  A61K31/728 ,  A61K36/906 ,  A23L33/10

Abstract: The present disclosure relates to a compound, method of making and method of using such compound preferably in the form of a dietary supplement. The composition, when administered, is capable of treating arthritis and various joint-related pain syndromes. The unique combination of the composition is preferably administered orally. A preferred composition is comprised of at least 10 to 200 mcg of selenium, from about 200 to 1200 mg of MSM, from about 100 to 900 mg of boswellia, from about 1 to 5 mg of type II collagen, from about 25 to 200 mg of hyaluronic acid, and from about 50 to 500 mg of ginger.